Article
Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug…
medRxiv · 2019 · Herviou, L.; IZARD, F.; Karmous-Gadacha, O.; Gourzones, C.; Bellanger, C.; Desmedt, E.; Ma, A.; Vincent, L.; Cartron, G.; Jin, J.; De Bruyne, E.; Grimaud, C.; JULIEN, E.; Moreaux, J.
Key facts
| Title | Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma |
|---|---|
| First author | Herviou, L.; IZARD, F.; Karmous-Gadacha, O.; Gourzones, C.; Bellanger, C.; Desmedt, E.; Ma, A.; Vincent, L.; Cartron, G.; Jin, J.; De Bruyne, E.; Grimaud, C.; JULIEN, E.; Moreaux, J. |
| Journal | medRxiv |
| Published | Sep 20, 2019 |
| DOI | 10.1101/776930 |
| Devices mentioned | K802418, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 2 more |
| Product codes mentioned | KIS, MVU, PFF, PFT |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1